Works matching AU Hubbard, JoLeen M.

Results: 30
    1

    Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance).

    Published in:
    2017
    By:
    • Hubbard, Joleen;
    • Mahoney, Michelle;
    • Loui, William;
    • Roberts, Lewis;
    • Smyrk, Thomas;
    • Gatalica, Zoran;
    • Borad, Mitesh;
    • Kumar, Shaji;
    • Alberts, Steven;
    • Hubbard, Joleen M;
    • Mahoney, Michelle R;
    • Loui, William S;
    • Roberts, Lewis R;
    • Smyrk, Thomas C;
    • Alberts, Steven R
    Publication type:
    journal article
    2
    3

    Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju106
    By:
    • Gonsalves, Wilson I.;
    • Mahoney, Michelle R.;
    • Sargent, Daniel J.;
    • Nelson, Garth D.;
    • Alberts, Steven R.;
    • Sinicrope, Frank A.;
    • Goldberg, Richard M.;
    • Limburg, Paul J.;
    • Thibodeau, Stephen N.;
    • Grothey, Axel;
    • Hubbard, Joleen M.;
    • Chan, Emily;
    • Nair, Suresh;
    • Berenberg, Jeffrey L.;
    • McWilliams, Robert R.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.

    Published in:
    Cancers, 2023, v. 15, n. 16, p. 4117, doi. 10.3390/cancers15164117
    By:
    • Ou, Fang-Shu;
    • Ahn, Daniel H.;
    • Dixon, Jesse G.;
    • Grothey, Axel;
    • Lou, Yiyue;
    • Kasi, Pashtoon M.;
    • Hubbard, Joleen M.;
    • Van Cutsem, Eric;
    • Saltz, Leonard B.;
    • Schmoll, Hans-Joachim;
    • Goldberg, Richard M.;
    • Venook, Alan P.;
    • Hoff, Paulo;
    • Douillard, Jean-Yves;
    • Hecht, J. Randolph;
    • Hurwitz, Herbert;
    • Punt, Cornelis J. A.;
    • Koopman, Miriam;
    • Bokemeyer, Carsten;
    • Fuchs, Charles S.
    Publication type:
    Article
    11
    12

    Comparing Oncologic Outcomes and Toxicity for Combined Modality Therapy vs. Carbon-Ion Radiotherapy for Previously Irradiated Locally Recurrent Rectal Cancer.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 3057, doi. 10.3390/cancers15113057
    By:
    • Jeans, Elizabeth B.;
    • Ebner, Daniel K.;
    • Takiyama, Hirotoshi;
    • Qualls, Kaitlin;
    • Cunningham, Danielle A.;
    • Waddle, Mark R.;
    • Jethwa, Krishan R.;
    • Harmsen, William S.;
    • Hubbard, Joleen M.;
    • Dozois, Eric J.;
    • Mathis, Kellie L.;
    • Tsuji, Hiroshi;
    • Merrell, Kenneth W.;
    • Hallemeier, Christopher L.;
    • Mahajan, Anita;
    • Yamada, Shigeru;
    • Foote, Robert L.;
    • Haddock, Michael G.
    Publication type:
    Article
    13
    14
    15

    Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35304
    By:
    • Tevaarwerk, Amye J.;
    • Karam, Dhauna;
    • Gatten, Clare A.;
    • Harlos, Elizabeth S.;
    • Maurer, Matthew J.;
    • Giridhar, Karthik V.;
    • Haddad, Tufia C.;
    • Alberts, Steven R.;
    • Holton, Sara J.;
    • Stockham, Abigail;
    • Leventakos, Konstantinos;
    • Hubbard, Joleen M.;
    • Mansfield, Aaron S.;
    • Halfdanarson, Thorvardur R.;
    • Chen, Ruqin;
    • Jochum, Jacob A.;
    • Schwecke, Anna S.;
    • Eiring, Rachel A.;
    • Carroll, Jamie L.;
    • Riaz, Irbaz Bin
    Publication type:
    Article
    16
    17
    18
    19
    20

    Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.

    Published in:
    2017
    By:
    • Katz, Matthew H. G.;
    • Fang-Shu Ou;
    • Herman, Joseph M.;
    • Ahmad, Syed A.;
    • Wolpin, Brian;
    • Marsh, Robert;
    • Behr, Spencer;
    • Qian Shi;
    • Chuong, Michael;
    • Schwartz, Lawrence H.;
    • Frankel, Wendy;
    • Collisson, Eric;
    • Koay, Eugene J.;
    • Hubbard, JoLeen M.;
    • Leenstra, James L.;
    • Meyerhardt, Jeffrey;
    • O'Reilly, Eileen;
    • Ou, Fang-Shu;
    • Shi, Qian;
    • Alliance for Clinical Trials on Oncology
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28

    A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
    By:
    • Ahn, Daniel H.;
    • Uson Junior, Pedro Luiz Serrano;
    • Masci, Peter;
    • Kosiorek, Heidi;
    • Halfdanarson, Thorvardur R.;
    • Mody, Kabir;
    • Babiker, Hani;
    • DeLeon, Thomas;
    • Sonbol, Mohamad Bassam;
    • Gores, Gregory;
    • Smoot, Rory;
    • Bekaii-Saab, Tanios;
    • Mahipal, Amit;
    • Mansfield, Aaron;
    • Tran, Nguyen H.;
    • Hubbard, Joleen M.;
    • Borad, Mitesh J.
    Publication type:
    Article
    29
    30